Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Hemoperfusion Devices for Experimental Animals

A technology of hemoperfusion and experimental animals, which is applied in the field of medical equipment, can solve the problems of short survival time, large trauma, and conflicts, and achieve the effects of simplifying hemoperfusion operations, maintaining a constant body temperature, and reducing the impact

Active Publication Date: 2016-08-24
SHENZHEN PREVENTION & TREATMENT CENT FOR OCCUPATIONAL DISEASES +1
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Due to the complex genetics and microbial background of hybrid dogs; and the high cost of experimental Beagle dogs and harsh breeding conditions, it is not convenient to use dogs as experimental animals to carry out experiments
There are also hemoperfusion experiments using rabbits as experimental animals. After general anesthesia, hemoperfusion is performed through carotid artery / venous cannulation. Surgery is required to separate the large blood vessels in the neck. The trauma is relatively large, the postoperative survival time is short, and the experimental operation is complicated.
General anesthesia drugs may also interfere with poison metabolism and hemoperfusion effect, affecting the objective evaluation of hemoperfusion effect
In addition, surgical wounds are prone to infection and bleeding, which increases the pain and accidental death of animals, increases the amount of animals used, and is also contrary to animal ethics and the "3R" principle

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Hemoperfusion Devices for Experimental Animals
  • Hemoperfusion Devices for Experimental Animals
  • Hemoperfusion Devices for Experimental Animals

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0063] Embodiment 1, the assembly of hemoperfusion device and the establishment of rabbit animal model

[0064] 1. Assembly of hemoperfusion device for experimental animals

[0065] 1. Sterilization of each part of the perfusion device

[0066] The tank body of the 20ml perfusion device was sterilized at 120°C for 15 minutes under high pressure, and dried for later use. The filter screen, the filter screen fixing ring, the sealing gasket, the head and the sealing bolt are soaked in a glutaraldehyde solution with a volume fraction of 2-2.5% for 60 minutes for disinfection, and rinsed with a large amount of sterile water for later use.

[0067] 2. Assembly of perfusator

[0068] Carry out in the ultra-clean bench, take 20ml HA230 adsorption resin and put it into the perfusion tank after step 1 sterilization, put the filter screen, filter screen fixing ring, sealing gasket and head at both ends of the tank body, and tighten the two ends to seal bolt. Pay attention to aseptic ...

Embodiment 2

[0081] Embodiment 2, the in vitro experiment of hemoperfusion to the removal effect of chlorpyrifos

[0082] In this embodiment, taking the organophosphorus insecticide chlorpyrifos (CPF) as an example, the effect of animal hemoperfusion system on blood poison removal is simulated through in vitro experiments.

[0083] One, the preparation of CPF pig blood solution

[0084] Take 500mL of fresh pig whole blood, add 10000IU heparin for anticoagulation, so that the final concentration of heparin in the pig blood solution is about 20IU / ml, and then add 2.5mg of CPF original drug to prepare a 5mg / L CPF pig blood solution.

[0085] Take another 500mL of fresh pig whole blood, add 10000IU heparin for anticoagulation, so that the final concentration of heparin in the pig blood solution is about 20IU / ml, and then add 5mg of CPF original drug to prepare a 10mg / L CPF pig blood solution.

[0086] 2. In vitro hemoperfusion experiment

[0087] 1. Pretreatment of hemoperfusion device

[0...

Embodiment 3

[0103] Embodiment 3, the animal experiment of hemoperfusion to chlorpyrifos removal effect

[0104] In this example, the organophosphorus insecticide chlorpyrifos (CPF) was taken as an example, and white Japanese white rabbits were used as experimental animals to evaluate the removal effect of animal hemoperfusion system on blood poisoning by using toxicokinetic indicators.

[0105] 1. Model preparation and grouping

[0106]After fasting for 12 hours, 12 Japanese white rabbits were fed with 480 g / L of CPF pesticide according to the dose of CPF 300 mg / kg body weight, and the poisoning was carried out by intragastric administration once. The animals were divided into 2 groups according to the random number table method, 6 animals in each group.

[0107] Control group: no hemoperfusion after exposure;

[0108] HP group: hemoperfusion started 1h after exposure, and continued for 2h.

[0109] 2. In vivo blood perfusion experiment

[0110] 1. Pretreatment of hemoperfusion device...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a blood perfusion device for experimental animals. The device provided by the present invention comprises an arterial indwelling needle, a three-way valve, a constant flow pump, a perfuser, an exhaust tube, an infusion heater and an intravenous indwelling needle connected in sequence through a catheter. The invention uses rabbits as experimental animals, establishes vascular access via the central ear artery and the marginal ear vein through local anesthesia, simplifies the blood perfusion operation, relieves the pain of the experimental animals, and reduces the influence on the experimental results. The indwelling needle is soft, does not damage the inner wall of the blood vessel, can be retained for a long time, and is convenient for multiple blood perfusion. The arterial end is connected with a three-way valve to facilitate blood collection and injection of anticoagulant and other drugs. The internal volume of the perfusion device is 20ml. The reduction of blood volume in rabbits during hemoperfusion has no obvious impact on the basic vital signs. After the perfusion beam, the blood in the system is returned to the animal body through a constant flow pump to reduce blood loss. An infusion warmer is installed at the venous end to compensate for the loss of extracorporeal circulation blood temperature and maintain a constant body temperature of the experimental animals.

Description

technical field [0001] The invention belongs to the field of medical equipment and relates to a blood perfusion device for experimental animals. Background technique [0002] Hemoperfusion (HP) is one of the commonly used blood purification methods in clinical practice. It draws the patient's blood from the body through puncture and other methods for extracorporeal circulation, and uses the adsorption of the adsorbent in the extracorporeal circulation perfusion device to remove exogenous blood. and blood purification treatment of endogenous toxins. Hemoperfusion for poisoning treatment generally uses activated charcoal or resin as the adsorbent material. Activated carbon is composed of criss-cross voids, and a large number of micropores constitute a huge specific surface area. The solute reaches the surface of activated carbon particles through the liquid phase, and then is adsorbed in the voids. This adsorption is non-specific and has a certain Adsorption. The resin main...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61D7/00
Inventor 郭翔张宏顺孙承业龙鑫何仟陈宵龚春梅黄先青何坚林辉郭美琼
Owner SHENZHEN PREVENTION & TREATMENT CENT FOR OCCUPATIONAL DISEASES
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products